FURIN and atherosclerosis: At present, several furin inhibitors, including smallmolecules158−161 and peptides,101,162−164 have been developed, but their clinical implications remain inconclusive.Furin inhibitor α-1-PDX recently demonstrated in vivo benefits in atherosclerosis,101 whichsupports the therapeutic significance of targeting furin.